Display options
Cite
Hedman L, Katsaounou PA, Filippidis FT, et al. Receiving support to quit smoking and quit attempts among smokers with and without smoking related diseases: Findings from the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2019;16:A14doi: 10.18332/tid/102787.
Hedman, L., Katsaounou, P. A., Filippidis, F. T., Ravara, S. B., Lindberg, A., Janson, C., Gratziou, C., Rohde, G., Kyriakos, C. N., Mons, U., Fernández, E., Trofor, A. C., Demjén, T., Przewoźniak, K., Tountas, Y., Fong, G. T., Vardavas, C. I. (2018). Receiving support to quit smoking and quit attempts among smokers with and without smoking related diseases: Findings from the EUREST-PLUS ITC Europe Surveys. Tobacco induced diseases, 16A14. https://doi.org/10.18332/tid/102787
Hedman, Linnea, et al. "Receiving support to quit smoking and quit attempts among smokers with and without smoking related diseases: Findings from the EUREST-PLUS ITC Europe Surveys." Tobacco induced diseases vol. 16 (2018): A14. doi: https://doi.org/10.18332/tid/102787
Hedman L, Katsaounou PA, Filippidis FT, Ravara SB, Lindberg A, Janson C, Gratziou C, Rohde G, Kyriakos CN, Mons U, Fernández E, Trofor AC, Demjén T, Przewoźniak K, Tountas Y, Fong GT, Vardavas CI. Receiving support to quit smoking and quit attempts among smokers with and without smoking related diseases: Findings from the EUREST-PLUS ITC Europe Surveys. Tob Induc Dis. 2019 Mar 20;16:A14. doi: 10.18332/tid/102787. eCollection 2018. PMID: 31516468; PMCID: PMC6661851.
Copy Download .nbib Format: NLM
Share it on

Tob Induc Dis. 2019 Mar 20;16:A14. doi: 10.18332/tid/102787. eCollection 2018.

Receiving support to quit smoking and quit attempts among smokers with and without smoking related diseases: Findings from the EUREST-PLUS ITC Europe Surveys.

Tobacco induced diseases

Linnea Hedman, Paraskevi A Katsaounou, Filippos T Filippidis, Sofia B Ravara, Anne Lindberg, Christer Janson, Christina Gratziou, Gernot Rohde, Christina N Kyriakos, Ute Mons, Esteve Fernández, Antigona C Trofor, Tibor Demjén, Krzysztof Przewoźniak, Yannis Tountas, Geoffrey T Fong, Constantine I Vardavas,

Affiliations

  1. The Tobacco Control Committee of the European Respiratory Society, Lausanne, Switzerland.
  2. Division of Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, The OLIN Unit, Umeå University, Umeå, Sweden.
  3. Contributed equally.
  4. National and Kapodistrian University of Athens (UoA), Athens, Greece.
  5. Department of Primary Care and Public Health, Imperial College, London, United Kingdom.
  6. Health Sciences Research Centre (CICS-UBI), Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal.
  7. Public Health Research Centre, National School of Public Health, NOVA University, Lisbon, Portugal.
  8. Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  9. Medical Clinic I, Department of Respiratory Medicine, Goethe University Hospital, Frankfurt, Germany.
  10. European Network for Smoking and Tobacco Prevention (ENSP), Brussels, Belgium.
  11. University of Crete (UoC), Heraklion, Greece.
  12. Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  13. Institut Català d'Oncologia and Bellvitge Biomedical Research Institute (IDIBELL), Catalonia, Spain.
  14. School of Medicine and Health Sciences, Universitat de Barcelona, Catalonia, Spain.
  15. University of Medicine and Pharmacy 'Grigore T. Popa' Iasi, Iasi, Romania.
  16. Aer Pur Romania, Bucharest, Romania.
  17. Smoking or Health Hungarian Foundation (SHHF), Budapest, Hungary.
  18. Health Promotion Foundation (HPF), Warsaw, Poland.
  19. Maria Sk?odowska-Curie Institute-Oncology Center (MSCI), Warsaw, Poland.
  20. Department of Psychology and School of Public Health and Health Systems, University of Waterloo (UW), Waterloo, Canada.
  21. Ontario Institute for Cancer Research, Toronto, Canada.

PMID: 31516468 PMCID: PMC6661851 DOI: 10.18332/tid/102787

Abstract

INTRODUCTION: Having a chronic disease either caused or worsened by tobacco smoking does not always translate into quitting smoking. Although smoking cessation is one of the most cost-effective medical interventions, it remains poorly implemented in healthcare settings. The aim was to examine whether smokers with chronic and respiratory diseases were more likely to receive support to quit smoking by a healthcare provider or make a quit attempt than smokers without these diseases.

METHODS: This population-based study included a sample of 6011 adult smokers in six European countries. The participants were interviewed face-to-face and asked questions on sociodemographic characteristics, current diagnoses for chronic diseases, healthcare visits in the last 12 months and, if so, whether they had received any support to quit smoking. Questions on smoking behavior included nicotine dependence, motivation to quit smoking and quit attempts in the last 12 months. The results are presented as weighted percentages with 95% confidence intervals (CI) and as adjusted odds ratios with 95% CI based on logistic regression analyses.

RESULTS: Smokers with chronic respiratory disease, those aged 55 years and older, as well as those with one or more chronic diseases were more likely to receive smoking cessation advice from a healthcare professional. Making a quit attempt in the last year was related to younger age, high educational level, higher motivation to quit, lower nicotine dependence and having received advice to quit from a healthcare professional but not with having chronic diseases. There were significant differences between countries with smokers in Romania consistently reporting more support to quit as well as quit attempts.

CONCLUSIONS: Although smokers with respiratory disease did indeed receive smoking cessation support more often than smokers without disease, many smokers did not receive any advice or support to quit during a healthcare visit.

Keywords: Chronic Obstructive Pulmonary Disease (COPD); chronic disease; quitting smoking; smoking cessation; tobacco smoking

Conflict of interest statement

The authors declare that they have no competing interests, financial or otherwise, related to the current work. A Lindberg reports personal fees from Boehringer-Ingelheim, from AstraZeneca, from Novar

References

  1. Fam Pract. 2003 Oct;20(5):520-3 - PubMed
  2. BMJ. 2004 Feb 7;328(7435):338-9 - PubMed
  3. Am J Public Health. 2005 Jun;95(6):1056-61 - PubMed
  4. Eur Respir J. 2007 Feb;29(2):390-417 - PubMed
  5. Eur Respir J. 2007 Mar;29(3):438-45 - PubMed
  6. Lancet. 2007 Sep 1;370(9589):765-73 - PubMed
  7. Nicotine Tob Res. 2008 Jan;10(1):55-61 - PubMed
  8. JAMA. 2008 May 7;299(17):2083-5 - PubMed
  9. Tob Control. 2008 Dec;17(6):410-5 - PubMed
  10. Drug Alcohol Rev. 2009 Sep;28(5):474-83 - PubMed
  11. Drug Alcohol Rev. 2009 Sep;28(5):484-97 - PubMed
  12. Expert Opin Pharmacother. 2011 Nov;12(16):2595-7 - PubMed
  13. Addiction. 2012 Jun;107(6):1066-73 - PubMed
  14. Tob Induc Dis. 2012 Oct 22;10(1):17 - PubMed
  15. N Engl J Med. 2013 Jan 24;368(4):351-64 - PubMed
  16. Arch Bronconeumol. 2011;47 Suppl 8:3-9 - PubMed
  17. J Health Care Poor Underserved. 2013 Aug;24(3):1306-16 - PubMed
  18. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
  19. Prev Med. 2015 Feb;71:77-82 - PubMed
  20. Addict Behav. 2015 Feb;41:124-8 - PubMed
  21. Eur Respir J. 2015 Jul;46(1):61-79 - PubMed
  22. Am J Prev Med. 2015 Jun;48(6):683-93 - PubMed
  23. Chest. 2016 Mar;149(3):676-84 - PubMed
  24. Tob Induc Dis. 2015 Aug 28;13(1):27 - PubMed
  25. NPJ Prim Care Respir Med. 2017 Dec;27(1):2 - PubMed
  26. Open Med (Wars). 2016 Dec 30;11(1):605-610 - PubMed
  27. NPJ Prim Care Respir Med. 2017 Jun 23;27(1):41 - PubMed
  28. J Clin Rheumatol. 2017 Aug;23(5):273-277 - PubMed
  29. NPJ Prim Care Respir Med. 2017 Sep 5;27(1):52 - PubMed
  30. Am J Med. 2018 Mar;131(3):318.e1-318.e8 - PubMed
  31. Tob Control. 2019 Jan;28(1):95-100 - PubMed
  32. ERJ Open Res. 2018 Jul 31;4(3):null - PubMed

Publication Types